` ACB (Aurora Cannabis Inc) vs S&P 500 Comparison - Alpha Spread

ACB
vs
S&P 500

Over the past 12 months, ACB has underperformed S&P 500, delivering a return of -31% compared to the S&P 500's 12% growth.

Stocks Performance
ACB vs S&P 500

Loading

Performance Gap
ACB vs S&P 500

Loading
ACB
S&P 500
Difference

Performance By Year
ACB vs S&P 500

Loading
ACB
S&P 500
Add Stock

Competitors Performance
Aurora Cannabis Inc vs Peers

Aurora Cannabis Inc
Glance View

Market Cap
281.5m USD
Industry
Pharmaceuticals

Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. The firm's principal business lines are focused on the production, distribution and sale of cannabis and cannabis related products in Canada and internationally. The firm's portfolio of brands includes Aurora, Aurora Drift, San Rafael '71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia; and Odense, Denmark. The firm is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets. The company produces approximately 150,000 kilograms (kg) of cannabis biomass annually. Its subsidiaries include 1769474 Alberta Ltd., 2105657 Alberta Inc., Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Aurora Nordic Cannabis A/S, and Reliva, LLC, among others.

ACB Intrinsic Value
8.47 USD
Undervaluation 39%
Intrinsic Value
Price
Back to Top